scindu funding
All calls

Levelling Course on Entrepreneurship in Healthcare 2027

Horizon Europe · Cascade funding

HORIZON-EIT-2025-KIC-IBA-H

Summary

Not an R&D call a Polish company can use, by Scindu's rule.

Supports an online healthcare entrepreneurship course; eligible applicant types are unspecified.

Who can apply
Unclear from the source.
Amount
€70K per projectTotal budget €70,000
Deadline
02 Nov 2026 17:00 CETin 9 days
Status
Openopened 2 Sept 2026
Open on the portalRegister to keep this call

Machine-classified from the call text; check eligibility at the source.

Description

Healthcare Entrepreneurship Levelling Online Course

Who can apply, in detail
Purpose
Training and people
R&D relevance
1 of 3
Poland eligible
Yes
Country limit
—
Region
Any
Consortium
Unclear
Readiness level (TRL)
—
Per project
€70K
Topics
  • Healthcare entrepreneurship
  • Online learning

Machine-classified from the call text; check eligibility at the source. 23 Oct 2026

Conditions11

Typed facts extracted from the source documents by Scindu's grant-data review. Each value keeps its own conditions. Unknown means unstated, not zero or unlimited.

Consortium required
Yes
Other condition
The current Annex II in the official share folder specifies EUR 6,500 per Revenue Share Period as the Operational Cost Threshold for the 2027 Levelling course, broken into EUR 1,000 learning platform/support, EUR 2,000 accreditation support, and EUR 3,500 overheads. This is an unsigned template parameter; executed Annex II was not available.
Other condition
The RSA template provides EIT Health an exclusive, worldwide, royalty-free, sublicensable licence to exploit project results for four years. It starts at project end, except when a learner pays during the project, in which case it begins at first paid enrolment or project end, whichever occurs earlier, and still continues for four years after project end.
Other condition
The linked FSA template shows pre-financing of 25% of the financial-support budget and a 75% balance of eligible financial-support costs. The call document separately makes its lump-sum payments conditional on completed and accepted work packages and final report approval. The documents do not fully reconcile whether/how the generic FSA percentage schedule is applied to these call-specific work-package lump sums; confirm the executed agreement before treating the percentages as the operative payment schedule.
Other condition
The call provides lump-sum funding paid according to completion and acceptance of work packages, with prefinancing and a final balance process.
Other condition
If Option A is selected, the RSA recovers the current-period and carried-forward operational-cost threshold before distributing net distributable revenues; remaining net distributable revenue is split 50% to EIT Health and 50% to partners, subject to project-specific Annex II allocation and waivers.
Other condition
If Option B is selected, the current Annex II provides a 20-seat pool for the consortium over the Exclusive Exploitation Period. The template lists EUR 656.25 per seat and EUR 13,125 total nominal value for indication only; unused seats lapse at period end, and option B replaces financial revenue-share entitlement with the fixed seat allocation. These are template terms, not confirmed executed entitlements.
Other condition
The call states that project intellectual property is owned by the consortium; the RSA template makes EIT Health the exclusive exploiter during the specified period and preserves later consortium exploitation rights under the template.
Other condition
Revenue sharing applies to standalone commercialisation of the accredited learning offer. The call says wider bundled programme use is outside revenue sharing unless otherwise specified in the RSA.
Other condition
Successful consortia must contract under a Revenue Sharing Agreement. Consortium members collectively select either revenue sharing or a seat-based voucher model; only the selected option binds, and individual members may waive their benefits.
Staff restriction
If personnel costs are charged under the executed FSA, time worked for the Recipient under the project must be documented by monthly declarations signed by the person and supervisor, unless another reliable time-recording system is used; the granting authority may accept alternative evidence it considers adequate. This is a recordkeeping condition, not proof that a particular position or personnel cost is eligible.
Amounts and costs4
Indicative budget
€70,000

Topic budget as stated in the portal's budget table. Lump-sum and per-project limits are in the call conditions.

Eligible cost
Selected applicants must sign the linked Financial Support Agreement. Its cost clause transposes Article 6 of the underlying Grant Agreement; costs or contributions declared ineligible are rejected. This establishes the governing eligibility framework, not a call-specific list of eligible occupations or a payroll reimbursement rate; the underlying option-specific Annex 2 rules were not resolved here.
Eligible cost
Eligible costs follow the Horizon Europe Model Grant Agreement. Subcontracting may cover only a limited part of the action, cannot replace beneficiaries’ own capacity to implement it, and a high subcontracting share is unlikely to be evaluated positively.
Own contribution, minimum
50
Project funding, maximum
€70,000
Source documents2
Call facts
Opens
2 Sept 2026
Deadline model
Single-stage
Programme
Horizon Europe · 2021 - 2027
Call
Levelling Course on Entrepreneurship in Healthcare 2027
Types of action
—
Checked
23 Oct 2026
Portal updated
14 Sept 2026
Review status
Partial review
Reviewed
22 Oct 2026

This is a summary of the source page, not the official text. Eligibility, conditions and the submission system are at the source.